Transaction · 0001193125-26-395853

Kushner Joshua

Kushner Joshua, CF, CHAIR, reported a transaction classified as other at Oscar Health, Inc. involving 1323589.000000 shares for an estimated $0.00. Reported holdings after the transaction were 4779730.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

otherSEC transaction code JCF, CHAIR
OSCROscar Health, Inc.
Trade date
Sep 18, 2026
Filing date
Sep 19, 2026
View on SEC Insider profile
Disclosed value$0Shares × reported price
Shares traded1.32M$0.00 per share
Holdings after4.77MIndirect · By Thrive Capital Partners II, L.P.
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
ambiguous transaction codeThe transaction code is missing or represents other activity; review the filing and footnotes.

OSCR price since this filing

Daily closing prices, with the filing date and available return windows
OSCR · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +0.5%1w ago +2.0%1d ago -0.5%
Returns since7d -7.9%30d -0.7%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
other
Code J
Identifier
0001193125-26-395853
Class B Common Stock
Transaction date
Sep 18, 2026
Filed Sep 19, 2026, 12:27 AM · 1d delay
Shares
1,323,589 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
4,779,730 sh
Indirect · By Thrive Capital Partners II, L.P.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Large Holdings Reduction
Filing-only score

-12 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Co-Founder and Vice Chairman

Officer YesDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    On September 18, 2026, (i) Thrive Capital Partners II, L.P. ("Thrive II") transferred 1,307,831 and 15,758 shares of Class B Common Stock to Thrive Capital Partners VII Growth, L.P. ("Thrive VII Growt…

  2. F2

    Thrive Partners II GP, LLC is the general partner of Thrive II; Thrive Partners III GP, LLC is the general partner of each of Thrive III and Claremount TW; Thrive Partners V GP, LLC is the general par…

  3. F3

    (continued from footnote 2) Thrive Partners II GP, LLC, Thrive Partners III GP, LLC, Thrive Partners V GP, LLC, Thrive Partners VI GP, LLC, Thrive Partners VII Growth GP, LLC and Thrive Partners VII G…

  4. F4

    On September 18, 2026, (i) Thrive II distributed to its limited partners and sole general partner, pro rata and without consideration, 1,323,589 shares of Class A Common Stock; (ii) Thrive III distrib…

  5. F5

    The Class B Common Stock is convertible at any time at the option of the holder into Class A Common Stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class…

Original filing · 0001193125-26-395853
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

OSCR